{
"@context": "https://schema.org",
"@type": "Article",
"headline": "PE Investment in Health Care Attracting Greater Federal Scrutiny",
"url": "https://www.lexblog.com/2021/07/14/pe-investment-in-health-care-attracting-greater-federal-scrutiny/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-FPGRVZB9",
"url": "https://www.lexblog.com/lib/FPGRVZB9/"
},
"datePublished": "2021-07-14T10:30:48-04:00",
"dateModified": "2021-07-14T12:54:09-04:00",
"author": {
"@type": "Person",
"name": "Health Care Litigation Group"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Goodwin Procter"
},
"organizationScope": "at-publication",
"isPartOf": "Life Sciences Perspectives",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.lifesciencesperspectives.com/2021/07/14/pe-investment-in-health-care-attracting-greater-federal-scrutiny/",
"sourceStability": "may-move"
}